The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

This was the stock's second consecutive day of losses.

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

NAW said Henry Schein’s CEO won the award for his leadership, service and engagement with the association and distribution ...

Henry Schein has opened the Henry Schein Cares Foundation 2025 Relief Fund to support those impacted by the Los Angeles area wildfires.

The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience ...

Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus.